Two things jump out at me:
1. Sell down suggests an inability to get substantial debt funding. Perhaps Senegal and deepwater combine as too risky for lenders. This would explain the recent cash raise, and lack of insider buying into that, despite the low price.
2. Presumably there has been some initial interest in the sell down, at levels above the current share price, that was suggested to instos during the placement. However if a really good offer was indicated, no placement would have been needed.
Net, net though, too risky for me.
- Forums
- ASX - By Stock
- FAR
- Jefferies snares $US2b SNE project mandate
Jefferies snares $US2b SNE project mandate, page-99
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
52.0¢ |
Change
0.005(0.97%) |
Mkt cap ! $48.05M |
Open | High | Low | Value | Volume |
51.0¢ | 52.0¢ | 50.0¢ | $79.61K | 155.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 39538 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 306286 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2495 | 0.495 |
1 | 47000 | 0.485 |
1 | 1999 | 0.475 |
2 | 92553 | 0.470 |
1 | 3000 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 306286 | 4 |
0.525 | 20000 | 1 |
0.530 | 101005 | 2 |
0.550 | 77285 | 3 |
0.555 | 10000 | 1 |
Last trade - 13.25pm 10/10/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online